Search by Drug Name or NDC

    NDC 68382-0896-05 Tadalafil 2.5 mg/1 Details

    Tadalafil 2.5 mg/1

    Tadalafil is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is TADALAFIL.

    Product Information

    NDC 68382-0896
    Product ID 68382-896_5a958db7-5c0e-4cf0-9227-230886cf9bf8
    Associated GPIs 40304080000302
    GCN Sequence Number 063691
    GCN Sequence Number Description tadalafil TABLET 2.5 MG ORAL
    HIC3 F2A
    HIC3 Description DRUGS TO TREAT ERECTILE DYSFUNCTION (ED)
    GCN 99409
    HICL Sequence Number 024859
    HICL Sequence Number Description TADALAFIL
    Brand/Generic Generic
    Proprietary Name Tadalafil
    Proprietary Name Suffix n/a
    Non-Proprietary Name Tadalafil
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 2.5
    Active Ingredient Units mg/1
    Substance Name TADALAFIL
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Phosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206693
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0896-05 (68382089605)

    NDC Package Code 68382-896-05
    Billing NDC 68382089605
    Package 500 TABLET, FILM COATED in 1 BOTTLE (68382-896-05)
    Marketing Start Date 2019-03-27
    NDC Exclude Flag N
    Pricing Information N/A